Table 3.
MR effect of severe COVID-19 on dyslipidemia.
| Exposure | Outcome | Beta | P |
|---|---|---|---|
| severe COVID-19 | Hyperlipidaemia | −0.042 | 0.299 |
| severe COVID-19 | apolipoprotein A | 0.005 | 0.436 |
| severe COVID-19 | apolipoprotein B | 0.011 | 0.298 |
| severe COVID-19 | HDL cholesterol | 0.001 | 0.789 |
| severe COVID-19 | triglycerides | −0.003 | 0.659 |
| severe COVID-19 | LDL cholesterol | 0.009 | 0.494 |
| severe COVID-19 | Ratio of apolipoprotein B to apolipoprotein A1 | 0.018 | 0.126 |
| severe COVID-19 | Total cholesterol | 0.012 | 0.346 |
| severe COVID-19 | VLDL cholesterol | 0.017 | 0.184 |
| severe COVID-19 | Lipoprotein A | −0.127 | 0.481 |
Note: Beta is the influence that exposure inflicts on the outcome, the higher the value the stronger the influence.